Cargando…
Should We Change the Target of Therapy in Pulmonary Hypertension?
Despite the evolution of drug therapy in pulmonary arterial hypertension and the more aggressive treatment approach according to the guidelines, patients continue to have unacceptable mortality rates. Furthermore, specific drug therapy alone in chronic thromboembolic pulmonary hypertension also does...
Autores principales: | Karyofyllis, Panagiotis, Demerouti, Eftychia, Habibis, Pavlos, Apostolopoulou, Styliani, Tsetika, Eleftheria-Garyfallia, Tsiapras, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221333/ https://www.ncbi.nlm.nih.gov/pubmed/37240847 http://dx.doi.org/10.3390/life13051202 |
Ejemplares similares
-
Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension in Greece: Data from the Hellenic Pulmonary Hypertension Registry
por: Karyofyllis, Panagiotis, et al.
Publicado: (2022) -
Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
por: Farmakis, Ioannis T., et al.
Publicado: (2021) -
The wide spectrum of β-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy
por: Anthi, Anastasia, et al.
Publicado: (2021) -
The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2022) -
Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2019)